Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
Public ClinicalTrials.gov record NCT02514577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \[IGA\] score of 3 or 4).
Study identification
- NCT ID
- NCT02514577
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 217 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 7, 2015 (Actual)
- Primary completion
- May 1, 2017 (Actual)
- Completion
- May 1, 2017 (Actual)
- Last update posted
- Jan 27, 2020
2015 – 2017
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 11 | Hot Springs | Arkansas | 71901 | — |
| Valeant Site 1 | Encinitas | California | 92023 | — |
| Valeant Site 10 | Encino | California | 91436 | — |
| Valeant Site 12 | Santa Rosa | California | 95401 | — |
| Valeant Site 13 | Atlanta | Georgia | 30301 | — |
| Valeant Site 7 | Boise | Idaho | 83701 | — |
| Valeant Site 6 | Rockville | Maryland | 20847 | — |
| Valeant Site 4 | Ann Arbor | Michigan | 48103 | — |
| Valeant Site 8 | Clarkston | Michigan | 48346 | — |
| Valeant Site 15 | Las Vegas | Nevada | 89101 | — |
| Valeant Site 9 | Raleigh | North Carolina | 27601 | — |
| Valeant Site 5 | Knoxville | Tennessee | 37901 | — |
| Valeant Site 3 | Austin | Texas | 73301 | — |
| Valeant Site 2 | San Antonio | Texas | 78201 | — |
| Valeant Site 14 | Spokane | Washington | 99201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02514577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02514577 live on ClinicalTrials.gov.